Cite
HARVARD Citation
Riedl, J. et al. (n.d.). P-286The AST/ALT (De Ritis) ratio predicts clinical outcome in pancreatic cancer patients treated with first-line nab-paclitaxel and gemcitabine: post-hoc analysis of an Austrian multicenter, non-interventional study. Annals of oncology. p. . [Online].